
Caplin Point Laboratories Ltd Surges 7.52% to Day's High of Rs 2281 — Outperforms Sector by 6.72 Percentage Points
2026-06-09 15:46:56The Sensex edged up 0.54% on 09 Jun 2026, but Caplin Point Laboratories Ltd outpaced the broader market with a 7.52% gain, reaching an intraday high of Rs 2281. This 6.72 percentage-point outperformance over the Pharmaceuticals & Biotechnology sector highlights a distinctly stock-specific rally rather than a market-wide lift.
Read full news article
Caplin Point Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Indicator Signals
2026-06-09 08:01:31Caplin Point Laboratories Ltd has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a mildly bullish trend on weekly charts. Despite mixed signals from key indicators such as MACD, RSI, and moving averages, the stock’s recent price action and relative strength against the Sensex suggest a cautiously optimistic outlook for investors in the Pharmaceuticals & Biotechnology sector.
Read full news article
Caplin Point Laboratories Ltd is Rated Sell
2026-06-08 10:10:57Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Caplin Point Laboratories Ltd is Rated Sell
2026-06-07 10:10:33Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
Caplin Point Laboratories Ltd is Rated Sell
2026-06-06 10:10:33Caplin Point Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 04 June 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 08 June 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Signals
2026-06-02 08:05:29Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in daily moving averages and a 1.66% decline in the latest session, the stock’s weekly and monthly technical indicators present a complex picture that investors should carefully analyse.
Read full news article
Caplin Point Laboratories Ltd Technical Momentum Shifts Signal Mild Bullish Outlook
2026-06-01 08:02:30Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has exhibited a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Recent technical indicators reveal a mixed but cautiously optimistic outlook, supported by strong price resilience and outperforming returns relative to the Sensex over multiple time horizons.
Read full news article
Caplin Point Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-05-29 08:02:47Caplin Point Laboratories Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade in daily moving averages and bearish weekly RSI readings, the stock’s monthly indicators present a more nuanced picture, reflecting a complex interplay of bullish and bearish signals that investors must carefully analyse.
Read full news article
Caplin Point Laboratories Ltd is Rated Hold
2026-05-26 10:10:03Caplin Point Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 14 May 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 May 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read full news articleCompliances-Reg.24(A)-Annual Secretarial Compliance
29-May-2026 | Source : BSEAnnual Secretarial Compliance report for the year ended March 31 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
22-May-2026 | Source : BSEIntimation of Schedule of Analyst / Institutional Investor Meeting under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
21-May-2026 | Source : BSETranscript for Earnings call- Q4- FY 2025-26
Corporate Actions
No Upcoming Board Meetings
Caplin Point Laboratories Ltd has declared 200% dividend, ex-date: 29 May 26
Caplin Point Laboratories Ltd has announced 2:10 stock split, ex-date: 19 Oct 16
No Bonus history available
No Rights history available






